Scientists found that dormant viral genes can be reactivated in kidney cancer, prompting an immune response, offering new potential for immunotherapy. Dana-Farber researchers have discovered that in ...

Are there key genes involved in TKI resistance in ccRCC? What mechanisms are associated with this development? A research team, led by Professor Ben Liu from the Department of Urology at the First ...

A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common ...

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

Specifically, following curative surgery in patients with high or intermediate risk of clear cell renal cell carcinoma (ccRCC ...

The following is a summary of “Retinoid X receptor γ predicts the prognosis and is associated with immune infiltration in ...

Lifetime excess body weight and significant weight gain in adulthood are associated with an increased risk for renal cell ...

Hedyeh Ebrahimi, MD, MPH, discusses updated data from a phase 1 study of CBM588, cabozantinib, and nivolumab in metastatic renal cell carcinoma.

Clear cell renal cell carcinoma (ccRCC) is still a clinical challenge due to its high metastasis rate at diagnosis and therapy resistance. It accounts for about 75%-80% of RCC cases. The magnesium ...

GAGome score had 90 percent sensitivity, 51 percent specificity for radiological recurrence, with AUC of 0.73 for nonmetastatic clear-cell renal cell carcinoma.

PD-32766 for patients with clear cell renal cell carcinoma (ccRCC) was conducted at the National Cancer Center Hospital East and promising results were obtained. PET positive rate: 64 Cu-PD-32766 was ...